MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET
Company Participants
Matt Notarianni – Head, Investor Relations
Joe Capper – Chief Executive Officer
Doug Rice – Chief Financial Officer
Conference Call Participants
Chase Knickerbocker – Craig-Hallum Group
Ross Osborn – Cantor Fitzgerald
Brad Bowers – Mizuho Securities
Carl Byrnes – Northland Capital Markets
Operator
Good afternoon, and thank you for standing by. Welcome to the MiMedx Third Quarter 2024 Operating and Financial Results Conference Call. At this time, all participants are in a listen-only-mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
I would now like to turn the conference call over to your host, Mr. Matt Notarianni, Head of Investor Relations of MiMedx. Thank you. You may begin.
Matt Notarianni
Thank you, operator, and good afternoon, everyone. Welcome to the MiMedx third quarter 2024 operating and financial results conference call. With me on today’s call are Chief Executive Officer, Joe Capper; and Chief Financial Officer, Doug Rice. As part of today’s webcast, we are simultaneously displaying slides that you can follow. You can access the slides from the Investor Relations website at mimedx.com.
Joe will kick us off with some opening remarks and a summary of our operating highlights, and Doug will provide a review of our financial results for the quarter, and then Joe will conclude with some additional updates, including a discussion of our financial goals. We will then be available for your questions.
Before we begin, I would like to remind you that our comments today will include forward-looking statements, including statements regarding future sales, operating results and cash balance growth, future margins and expenses, our product portfolios and expected market sizes for our products. These expectations are subject to risks and uncertainties, and actual results may differ materially
Read the full article here
